Clover Health Investments (CLOV) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Clover Health Investments (CLOV) do?
Clover Health Investments Corp (CLOV) is a U.S.-listed company in Healthcare (Healthcare Plans). What it does: Sells Medicare Advantage health insurance plans to seniors in select American states. Provides clinical workflow software to network physicians to monitor chronic conditions. Integrates proprietary diagnostic software into primary care workflows to manage Medicare Advantage patient health. It is worth $2.00B on the market and sold $2.74B over the last year.
- Market cap
- $2.00B
- P/E ratio
- 199.5×
- Annual sales
- $2.74B
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Brief updated
- Nov 15, 2026
Brands and businesses behind CLOV
- Counterpart Health: Licenses clinical management software to external healthcare organizations to generate recurring technology fees.
CLOV’s flags, in plain English
Each flag is a number from Clover Health Investments’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 15, 2026.
Low debt
Low debt, only 0% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Earnings Jumping
Profits up 66.8% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.
Growth vs Price
The price looks reasonable for how fast it is growing. The price looks reasonable for how fast its profits are growing.
Priced for Perfection
Priced at 199.5 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags open with the free trial. Try it free for 7 days.
Questions about CLOV
How big is Clover Health Investments?
Clover Health Investments’ market cap is $2.00B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $2.74B: what customers paid the company over the last year, before any costs.
What is CLOV’s P/E ratio?
CLOV’s P/E ratio is 199.5×. Investors pay about 199.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with CLOV?
Federal regulators determine Medicare Advantage reimbursement formulas and Star Ratings that heavily dictate annual revenue. That is one risk on Clover Health Investments’ card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Clover Health Investments’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. CLOV’s filings on SEC.gov. The Margin Monkey is research, not advice.
